Schedule 13G ownership disclosure

PIERIS PHARMACEUTICALS INC

Security class unavailable · CUSIP: 720795103

Event date: 2020-03-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,543,848
Percent of class
8.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001591986-20-000009
Form type
SC 13G/A
Filer
Aquilo Capital Management, LLC
CIK
CIK 1591986
Filed
Apr 22, 2020
Reporting period
Mar 31, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub